Cancer Related News
Pioneering approaches to gynaecological cancer diagnostics
Lorna Rothery spoke to Marina Rigau, CEO and Co-Founder of EIT Health-supported start-up MiMARK, about the challenges associated with the diagnosis of gynaecological conditions.
By...
Challenges and opportunities for cervical screening and HPV vaccine uptake
Despite being one of the most preventable and treatable forms of cancer, many barriers to cervical cancer screening and HPV vaccine uptake exist. We...
The importance of sex differences in pancreatic cancer treatment
Researchers from Karolinska Institutet have found that certain immune cells in women with pancreatic cancer can obstruct their immune response.
The findings may explain differences...
Defence Therapeutics and Orano agree to collaborate on radio-immuno-conjugates
Defence Therapeutics Inc. is pleased to announce that they have signed a collaboration agreement with Orano to develop next-generation radio-immuno-conjugates using their intracellular targeting...
Delaying treatment for prostate cancer does affect survival rates
According to a new study from the universities of Bristol and Oxford, delaying treatment for prostate cancer does not increase the risk of mortality.
The...
New AI method for diagnosing prostate cancer begins trial in Oxford
An Artificial Intelligence (AI) software that helps with diagnosing prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.
Researchers...
New bone cancer treatment could save children’s lives
Researchers at the University of East Anglia and The University of Sheffield have developed a new bone cancer treatment for children.
Currently, bone cancer treatment...
Researchers have developed a revolutionary new bone cancer treatment
Researchers from the University of East Anglia (UEA) have developed a new, non-invasive bone cancer treatment that is effective against all primary forms of...
Meet the women at the forefront of digital oncology
Creation Healthcare has marked this year's International Women’s Day (IWD) by highlighting five women leading the way in digital oncology.
The theme of this year's...
UK lung cancer death rates are predicted to fall in 2023
A new study by the University of Milan has found that cancer death rates will fall by 6.5% in men and 3.7% in women.
A...
People with a history of atopy are less like to develop melanoma
A study from the University of Eastern Finland found fewer cases of melanoma and skin cancer in people with a history of atopy.
Atopy refers...
Vitamin B5 could be the key to improving myelodysplastic syndrome care
Vitamin B5 could improve the production of red blood cells in myelodysplastic syndrome patients, according to new research from Queen Mary University of London.
Researchers...
Defence advances to phase I clinical trials of the Accum technology
Defence Therapeutics Inc. is pleased to update its stakeholders on its completed achievements and outline the future milestones for AccumTM set for 2023.
Over the...
Doctors can now asses the likelihood of kidney cancer recurrence
An international study into kidney cancer recurrence has found that doctors can predict the likelihood of a patient’s disease returning by examining DNA mutations...
A new targeted treatment for acute myeloid leukaemia has been approved
A new targeted drug for treating acute myeloid leukaemia has been granted authorisation following a study from the University of Helsinki.
The aim of targeted...
How a protein found in foetal development can prevent acute leukaemia
Researchers have identified a protein present in foetal development that has a strong prophylactic effect against acute myeloid leukaemia (AML).
During the foetal stage of...
NHS launch a nationwide bowel cancer test kit campaign
The NHS has sent millions of people in the UK a potentially lifesaving bowel cancer test kit as part of a nationwide campaign to...
Defence work with City of Hope in filing a new AccuTOX cancer programme
Defence Therapeutics has teamed up with City of Hope to submit an application for the clinical trialling of their AccuTOX TM technology.
The Canadian biopharmaceutical...
Radiotherapy does not improve survival rates for older patients
Adding radiotherapy to the current standard treatment for breast cancer did not improve survival rates for patients aged 65 years or older.
Radiotherapy is a...
Nearly four in ten women missed out on breast cancer screening
New figures reveal that almost four in ten women did not take up the breast cancer screening offered in 2022.
Thousands of women have now...
